Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Asetek – Update on Q1 2023 Selected Preliminary Financial Figures and Updated Medium-term Ambitions

Aalborg, Denmark - April 18, 2023. Asetek today reports selected preliminary, unaudited, financial figures for the first quarter of 2023. Asetek expects to report revenue of USD 14.7 million for the three months ended March 31, 2023. Gross profit is expected at USD 6.5 million and operating income (EBIT) at USD 1.0 million. The results are primarily a function of revenues on par with the first quarter of 2022, an improved gross margin and significantly lower operating expenses. The gross margin improvement is attributable to, among other factors, a ‘richer’ product mix, increased

Idogen is investigating reverse acquisitions to avoid risk of liquidation

Idogen's work on capitalization has not yet achieved the required result. Idogen is now evaluating, among other things, the possibility of a reverse acquisition. If capital is not added to the company, the board will propose a liquidation.   ”Idogen announced in a press release on April 3 that the funds will last until the end of June. The work on this year's capitalization has not yet obtained  the required result. Idogen is now investigating, among other things, the possibilities for a reverse acquisition (i.e. another company takes over Idogen's listing at the stock market through

Inside information: Tecnotree Corporation announces its intent to issue compulsory convertible debentures valued at EUR 30 million

Tecnotree Corporation inside information 18 April 2023 at 9:01 EETTecnotree Corporation (“Issuer”) declares its intention to launch a transaction involving the issuance of compulsory convertible debenture notes ("Notes") valued at EUR 30 million in total (300 Notes valued at EUR 100,000 each). This initiative aims to bolster Tecnotree's research and development efforts, broaden its current product portfolio, finance mergers and acquisitions. In addition, the funds could be used to repurchase outstanding Tecnotree shares for general treasury, corporate activities, incentive schemes, share

Publishing of Apetit Plc’s Business Review for January-March 2023

Apetit Plc, Press release, on 18 April 2023 at 09:00 a.m.Apetit Plc will publish its Business Review for January-March 2023 on Tuesday 25 April 2023 at 8.30 a.m. A separate press conference in relation to the Business Review will not be arranged. Apetit Plc For further information, please contact: Miika Kemilä, Communications and Sustainability Manager, +358 10 402 4044 Apetit is a food industry company firmly rooted in Finnish primary production. Our operations are based on a unique and sustainable value chain: we create well-being with vegetables by offering tasty food

Katalysen Ventures forms strategic partnership with issuing specialist Nordic Issuing

Katalysen Ventures has initiated a strategic partnership with Sweden-based issuing specialist Nordic Issuing. Through this collaboration, Katalysen Ventures will be able to ensure that its portfolio companies can access a broad range of issuing services, including services related to IPO´s, rights issues, warrant redemptions, public takeover offers and directed issues."We're very excited to be partnering with Nordic Issuing, a team of issuing specialists that we have gotten to know and trust first hand" said Peter Almberg, CEO of Katalysen Ventures. "As our portfolio companies continue to

Poster Presentations at AACR 2023

Faron Pharmaceuticals Oy   ("Faron" or the "Company")   Faron Pharmaceuticals Announces Poster Presentations on Bexmarilimab at the American Association for Cancer Research Annual Meeting 2023   Press Release, April 18, 2023     TURKU, FINLAND / BOSTON, MA: Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces the presentation of two posters at the American Association for Cancer Research Annual Meeting 2023 in Orlando, Florida.   Details of the

Deutsche Bahn to purchase 13,000 tons of Neste MY Renewable Diesel

Neste Corporation, Press Release, 18 April 2023 at 9.00 a.m. (EET) Photo: Copyright DB AG/ Adam ÖzdemirDeutsche Bahn is expanding its use of renewable diesel significantly this year by purchasing around 13,300 tons (17 million liters) of renewable diesel produced by Neste. Switching from fossil diesel to Neste MY Renewable Diesel™  will enable Deutsche Bahn to reduce greenhouse gas emissions from the operation of their diesel-powered locomotives and railcars by up to 90 %*. In total,

Peab renovates rental apartments in Helsinki

Peab has been commissioned to carry out an extensive renovation of rental apartments for Helsingin kaupungin asunnot Oy (HEKA) in Herttoniemi in Helsinki. The contract is worth EUR 18 million.The renovation project is for an eight story apartment building from 1961 with 150 apartments owned by Heka. The building’s HVAC, plumbing, electrical and building automation systems as well as the elevators will all be updated. The renovation also includes the stairwells, saunas, laundry rooms and common areas. The outer renovation consists of additional insulation and plastering the facade, putting

Tecnotree Corporation Interim Report 1 Jan – 31 Mar 2023 (unaudited)

Tecnotree Corporation Stock Exchange Release 18 April 2023 at 9.00 EETSTRONG GROWTH IN REVENUE AND PROFITABILITY First quarter (1[st] Jan – 31[st] Mar 2023) · Net sales increased 17.0% to EUR 15.5 (13.3) million. · Operating result increased 80.5% to EUR 3.6 (2.0) million. · Net result increased by 79.2% to EUR 1.8 (1.0) million.   · Order book at the end of the period stood at EUR 67.8 (64.0) million. · Cash flow after investments was EUR -0.4 (-2.1) million. · Earnings per share were EUR 0.01 (0.00) Key figures, MEUR 1-3/2023 1-3/

Changes in Nixu Corporation's Management Team: Pauliina Nikko-Takala appointed to the Leadership Team with responsibility for Marketing and Communications

Nixu Corporation, Stock Exchange Release on 18 April 2023 at 9.00 a.m.Pauliina Nikko-Takala will join the Nixu Corporate Leadership team on 18 April 2023 as Chief Marketing and Communications Officer. She will report to CEO Teemu Salmi. She has been Nixu's Head of Marketing and Communications since October 2021. In this new Leadership Team position, she is responsible for building a strong brand image, and driving client-centricity and business growth through marketing and communications. Pauliina is an experienced marketing and communications professional with over 20 years of

Insight Partners announces offer document in respect of the recommended public cash offer to the shareholders of SignUp Software AB (publ)

The Offer (as defined below) is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa, or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law (including the Takeover

Hexagon Purus and Panasonic Energy sign multi-year supply agreement for battery cells in North America

(Oslo, Norway, 18 April 2023) Hexagon Purus Systems USA LLC, a subsidiary of Hexagon Purus ASA (“Hexagon Purus”), a world leading manufacturer of zero emission mobility and infrastructure solutions, has signed a multi-year agreement for the supply of lithium-ion battery cells with Panasonic Energy Co., Ltd. (“Panasonic”), a global provider of innovative battery technology-based products and solutions. Panasonic will supply battery cells for Hexagon Purus’ proprietary battery systems, marking yet another important milestone for Hexagon Purus’ zero-emission heavy-duty offering in North

Readly brings forward the publication of the report for the first quarter 2023

Readly's Board of Directors has decided to advance the publication of the quarterly report for the first quarter of 2023 from the previously communicated date of May 4 to April 25.That way the report is made available prior to the extra general meeting on April 26. This cancels the audiocast, teleconference and presentation. The report will be available for download on https://corporate.readly.com/investors/financial-reports-and-presentations/ For more information, please contact:Linnea Aguero, Head of PR and Communications+46 72 503 32 31, linnea.aguero@readly.com About Readly

Panoro Energy – Acquisition of Minority Share in Panoro’s Tunisian Business

Oslo, 18 April 2023 – Panoro Energy ASA (“Panoro” or the “Company”) is pleased to announce that it has entered into a definitive agreement with Beender Tunisia Petroleum Limited (“Beender”) to acquire its 40 percent shareholding in Sfax Petroleum Corporation AS (“SPC”) for a total consideration of approximately USD 18.2 million in a mix of cash and shares (the “Acquisition”). SPC through its subsidiaries, indirectly owns a 49 percent interest in the producing TPS Assets which comprise five oil field concessions in the region of the city of Sfax, onshore and offshore shallow water Tunisia,

Neogap presents innovative tumour-targeting T-cell therapy at Neoantigen Summit Europe

Neogap Therapeutics, a biotech company specialising in personalised immunotherapy, is pleased to announce that Ola Nilsson, Head of Neoantigen Production and Development, will present the company’s innovative cell therapy pTTL at the 6th Annual Neoantigen Summit Europe in Amsterdam on the 24th - 26th of April. The summit is dedicated to advancing personalised therapeutic development through the discovery of exclusive tumour antigens.During the presentation, Ola Nilsson will showcase Neogap's advanced software PIOR[®] for neoantigen prediction and selection and the innovative EpiTCer[®]

Eevia Health Plc receives new sales order for Feno-Sambucus™ from Australia for 450 KSEK / 40 KEUR

Eevia Health ("Eevia" or "The Company") received a 450 KSEK / 40 KEUR sales order for the Feno-Sambucus™ from its Australian distributor Ingredient Plus. The order is the second order from an Australian brand owner.The end customer is a well-established player within innovative complementary medicines in Australia, marketing and selling a targeted product range, combining nutrients, herbal, and other ingredients. It is a leading supplier of traditional remedies which are available in over five thousand pharmacies and health food stores across Australia. Their focus is on mums’ and

How electricity can heal wounds three times as fast

Chronic wounds are a major health problem for diabetic patients and the elderly – in extreme cases they can even lead to amputation. Using electric stimulation, researchers in a project at Chalmers University of Technology, Sweden, and the University of Freiburg, Germany, have developed a method that speeds up the healing process, making wounds heal three times faster. There is an old Swedish saying that one should never neglect a small wound or a friend in need. For most people, a small wound does not lead to any serious complications, but many common diagnoses make wound

BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR

- In addition to STK11 mutations, KEAP1m identified as being associated with STK11 loss of function - - STK11 loss of function correlated to AXL activation and poorer outcomes in NSCLC -   BERGEN, Norway, April 18, 2023 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that it presented data linking AXL activation to STK11 loss of function in Non-Small Cell Lung Cancer (NSCLC) in an abstract titled, AXL as a Therapeutic Target in STK11 mutant NSCLC, at the

Kesko’s sales in March

Kesko Group's sales in March 2023 totalled €1,100.5 million, representing an increase of 0.4% in comparable terms.”Sales in March grew in grocery trade and car trade. In grocery trade, sales growth was particularly strong in Kespro. Easter this year was one week earlier than last year, which had a positive impact on sales in grocery trade. Sales in building and technical trade declined markedly compared to March 2022, when the Russian attack on Ukraine led to hoarding and exceptionally high sales. In car trade, sales rose to an all-time high as availability improved,” says Kesko’s President

OXE Marine AB (publ) publishes annual report for 2022

MANAGEMENT REPORT Information about the business OXE Marine AB (publ) was formed in 2012 and after several years of development has developed a diesel outboard for the marine market. The head office is located in Ängelholm, Sweden. OXE Marine AB is listed on Nasdaq First North Growth Market, ISIN SE0009888613. The global outboard market has long been dominated by gasoline engines, but with a diesel engine you get a stronger and, above all, a more fuel-efficient engine. Several attempts have been made to develop outboard engines for diesel fuel, but the difficulty lies in developing

Ericsson reports first quarter results 2023

First quarter highlights – Executing in a challenging market · Group organic sales[1] were unchanged YoY. As expected, segment Networks organic sales[1] declined by -2%, driven by lower operator capex and inventory optimization among multiple customers. The decline was offset by growth in other business segments. Reported sales increased to SEK 62.6 (55.1) b. · Gross income excluding restructuring charges increased to SEK 24.9 (23.3) b. mainly driven by Enterprise as well as Cloud Software and Services. Reported gross income was SEK 24.2 (23.3) b. · Gross margin excluding

Joint industry initiative aims to develop the feed of the future: Insects and mussels to replace wild-caught fish and soya

Axfoundation and the Swedish University of Agricultural Sciences (SLU) are bringing together practitioners and researchers from across Sweden to develop the feed of the future for poultry, laying hens, fish, and pigs. The ambition is for unsustainable ingredients in conventional feed, such as imported soya and wild-caught fish, to be replaced with more resource-efficient and circular ingredients that have a significantly lower environmental and climate impact. Particularly interesting ingredients currently being explored include insects that eat food waste, mycoprotein produced using

Ethereum Could be Heading for $3,000 this Month, While Ecoterra is on its Way to $3 Million

Ethereum has been one of the best-performing crypto tokens of 2023 so far and shows no signs of slowing down - with analysis showing ETH could reach $3,000 by the end of April. The bullish prediction follows its hugely successful Shanghai upgrade last week, which allows those who staked ETH to unstake and access it for the first time.While many predicted the upgrade would see huge withdrawals and ETH flooding the market, driving its price down, that has not happened - in fact, significantly more validators are now staking ETH. Ethereum has long been a favorite for crypto investors and

Desert Control AS – Sale of shares by board member

ISSUER DESERT CONTROL AS Sandnes, Norway, 17 April 2023: A member of the board of directors in DesertControl AS ("Desert Control" or the "Company") have on 17 April 2023 sold sharesin the company.Brage Johansen, a member of the board of directors of the Company, has throughBeyond Centauri AS sold 300 000 shares in the Company at an average price of NOK13.97. The sale is primarily to settle tax obligations. Following thetransaction, Beyond Centauri holds a total of 943 371 shares in the Company.Primary insider notification pursuant to the market abuse regulation article

There are no items matching the current filter
There are no more items matching the current filter
Back to top